Correlation Between Pliant Therapeutics and Karuna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Karuna Therapeutics, you can compare the effects of market volatilities on Pliant Therapeutics and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Karuna Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Karuna Therapeutics
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Pliant and Karuna is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Karuna Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Karuna Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 3.8 times less return on investment than Karuna Therapeutics. In addition to that, Pliant Therapeutics is 1.62 times more volatile than Karuna Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. Karuna Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 19,728 in Karuna Therapeutics on August 30, 2024 and sell it today you would earn a total of 583.00 from holding Karuna Therapeutics or generate 2.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 31.31% |
| Values | Daily Returns |
Pliant Therapeutics vs. Karuna Therapeutics
Performance |
| Timeline |
| Pliant Therapeutics |
| Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pliant Therapeutics and Karuna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Karuna Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.| Pliant Therapeutics vs. Bright Minds Biosciences | Pliant Therapeutics vs. HP Inc | Pliant Therapeutics vs. Intel | Pliant Therapeutics vs. Chevron Corp |
| Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |